Hepatitis - B Therapeutics Market | Global Market Analysis Report - 2035

Future Market Insights

Hepatitis - B Therapeutics Market

Key Insight

The hepatitis - b therapeutics market is projected to grow from USD 2.7 billion in 2025 to USD 9.9 billion by 2035, at a CAGR of 14.1%. Anti-Viral Drugs will dominate with a 26.2% market share, while hospitals pharmacies will lead the distribution channel segment with a 42.8% share.

September 12, 2025

Anurag Sharma

250 Pages

Cite this Report

Hepatitis - B Therapeutics Market

https://www.futuremarketinsights.com/reports/hepatitis-b-therapeutics-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Aligos Therapeutics
Arbutus Biopharma
Assembly Biosciences
Barinthus Biotherapeutics
Bristol-Myers Squibb
Excision BioTherapeutics
GSK plc
Gilead Sciences

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Hepatitis - B Therapeutics Market

Key Players

Similar Industry Reports